Comparative Effects of Some Serum Components and Proteolytic Products of Fibrinogen on Surface Tension-Lowering Abilities of Beractant and a Synthetic Peptide Containing Surfactant KL41

Pediatric Research

Volumn 39, Issue 6, 1996, Pages 947-952

  Manalo, Erlinda ^a   Merritt, T Allen ^a,c   Kheiter, Ahmed ^a   Amirkhanian, John ^a   Cochrane, Charles ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; LEUKOCYTE ELASTASE; LUNG SURFACTANT; LYSOPHOSPHATIDYLCHOLINE; PALMITIC ACID; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; PLASMIN; PROTEIN INHIBITOR; PROTEINASE; SYNTHETIC PEPTIDE; TRYPSIN;

ARTICLE; DRUG EFFECT; FIBRINOGENOLYSIS; LUNG ALVEOLUS SURFACE TENSION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESPIRATORY DISTRESS SYNDROME;

AMINO ACID SEQUENCE; BIOLOGICAL PRODUCTS; C-REACTIVE PROTEIN; FIBRINOGEN; LYSOPHOSPHATIDYLCHOLINES; MOLECULAR SEQUENCE DATA; PEPTIDES; PULMONARY SURFACTANTS; SURFACE TENSION;

EID: 0029951657     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199606000-00004     Document Type: Article

References (35)

1. Ueda T, Ikegami M, Jobe A 1994 Surfactant subtypes, in vitro conversion, in vivo function, and effects of serum proteins. Am J Respir Crit Care Med 149:1254-1259
2. Higuchi R, Lewis J, Ikegami M 1992 In vitro conversion of surfactant subtype is altered in alveolar surfactant isolated from injured lungs. Am Rev Respir Dis 145:1416-1420
3. Seeger W, Stoehr G, Wolf HRD, Neuhof H 1985 Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58:326-338
4. Holm BA, Enhorning G, Notter RH 1988 A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipid 49:49-55
5. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G 1987 Artificial pulmonary surfactant inhibited by proteins. J. Appl Physiol 62:429-437
6. Tierney DF, Johnson RP 1965 Altered surface tension of lung extracts and lung mechanics. J Appl Physiol 20:1253-1260
7. Seeger W, Lepper H, Wolf HRD, Neuhof H 1985 Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. Biochim Biophys Acta 835:58-67
8. Oosting RS, van Greenvenbroek MMJ, Verhoef J, van Golde LMG, Haagsman HP 1991 Structural and functional changes of surfactant protein A induced by ozone. Am J Physiol 261:L77-L83
9. Merritt TA, Amirkhanian JD, Helbock H, Halliwell B, Cross CE 1993 Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid. Biochem J 295:19-22
10. Haddad I, Ischiropoulos M, Holm B, Beckman J, Barker J. Matalon S 1993 Mechanism of peroxynitrite-induced injury to pulmonary surfactant. Am J Physiol 265:L555-L564
11. Amirkhanian JD and Taeusch HW 1993 Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents. Biochim Biophys Acta 1165:321-326
12. Cochrane CG and Revak SD 1991 Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 254:566-568
13. Cochrane CG and Revak SD 1994 Protein and phospholipid interaction in pulmonary surfactant. Chest 105:57S-62S
14. Bartlett GR 1959 Phosphorus assay in column chromatography. J Biol Chem 234:466-468
15. Seeger W, Grube C, Günther A 1993 Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity. Am J Cell Mol Biol 9:239-247
16. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
17. Deleted in proof
18. Enhorning G 1977 Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43:198-203
19. Amirkhanian JD, Merritt TA 1995 The influence of pH on surface properties of lung surfactants. Lung 173:243-254
20. Hallman M, Spragg R, Harrell JH, Moser KM 1982 Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 70:673-683
21. Taylor F, Abrams J 1966 Effect of surface active lipoprotein on clotting and fibrinolysis and fibrinogen on surface tension of surface active lipoproteins. Am J Med 40:346-350
22. Idell S, James KK, Levin EG. Schwartz BS, Manchanda N, Maunder RJ, Martin TR, Mclarty J, Fair DS 1989 Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the ARDS. J Clin Invest 84:695-705
23. Sitrin R, Brubaker P, Fentone J 1987 Tissue fibrin deposition during acute lung injury in rabbits and its relationships to local expression of procoagulant and fibrinolytic activities. Am Rev Respir Dis 135:930-936
24. Seeger W, Elssner A, Günther A, Krämer HJ 1993 Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. Am J Respir Cell Mol Biol 9:213-220
25. Kume N, Gimbrone MA 1994 Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93:907-911
26. Zahedi K, Mortensen RF 1986 Macrophage tumoricidal activity induced by human C-reactive protein. Cancer Res 46:5077-5083
27. Hallman M, Merritt TA, Akino T, Bry K 1991 Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in the epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 144:1376-1384
28. Ikegami M, Jobe AH, Glatz T 1981 Surface activity following natural surfactant treatment of premature lambs. J Appl Physiol 51:306-312
29. Hall S, Venkitarranan A, Whitsett J, Holm B, Notter R 1992 Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 145:24-30
30. Cockshutt AM, Weitz J, Possmayer F 1990 Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29:8424-8429
31. Amirkhanian JD, Bruni R, Waring AJ, Taeusch HW 1991 Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C. Biochim Biophys Acta 1096:355-360
32. Amirkhanian JD, Bruni R, Waring AJ, Navar C, Taeusch HW 1993 Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum. Biochim Biophys Acta 1168:315-320
33. Mizuno K, Ikegami M, Chen CM, Ueda T, Jobe A 1994 In vivo function of the modified natural surfactant Survanta®. Pediatr Res 35:345A(abstr)
34. Bloom BT, Delmore P, Kattwinkel J, Carlo W, Malloy M, Holzman I, Hall RT, Pramanik P et al 1994 Randomized double blind multicenter trial of Survanta® and Curosurf®. Pediatr Res 35:326A(abstr)
35. Seeger W, Günther A, Thede C 1992 Differential sensitivity to fibrinogen inhibition of SP-C and SP-B based surfactants. Am J Physiol 261:L286-L291